Molecular Phenotype Neural Networks for Variant Impact Prediction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing the impact of biological sequence variants on molecular phenotypes are manual, time-consuming, prone to human error, and result in high false negative rates, especially in precision medicine and therapeutic design.
Innovation Solution
A system and method using molecular phenotype neural networks (MPNNs) to automatically analyze biological sequence variants by determining molecular phenotypes and link distances between variants, incorporating conservation information for improved accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If manual examination of variants is used, then human expertise and contextual understanding are applied, but the process is time-consuming, costly, and prone to human error
Solution Approach 1:
The patent replaces manual mechanical examination of variants with an automated neural network system. The neural network automatically processes variant data, predicts molecular phenotypes, and identifies disease associations without human intervention, thereby eliminating time consumption and human error while maintaining diagnostic accuracy through learned patterns from training data.
Solution Approach 2:
The neural network system performs self-service by automatically analyzing variants, predicting molecular phenotypes, and generating diagnostic insights without requiring manual expertise. The system uses its own learned models and training data to perform the analysis independently, reducing dependency on human analysts and enabling scalable processing.
2Measurement precision
If manual variant analysis is performed, then expert judgment is applied, but the system becomes highly dependent on previous literature and experimental data with poor coverage
Solution Approach 1:
The patent changes the approach from literature-based expert judgment to data-driven neural network predictions. The system processes variant data through multiple layers of neural networks that learn patterns from genomic sequences and predict molecular phenotypes directly, enabling accurate assessment of variants not covered in previous literature by generalizing from learned representations.
Solution Approach 2:
The neural network system provides universal functionality by handling diverse variant types and contexts through a single integrated model. The system can analyze different molecular phenotypes, tissue types, and disease associations simultaneously, making it versatile and adaptable to various genetic analysis tasks without requiring separate specialized systems for each function.
3Productivity
If automated neural networks are used, then analysis speed and consistency are improved, but the system complexity increases
Solution Approach 1:
The patent segments the complex neural network into distinct functional modules: input processing layers for variant encoding, hidden layers for pattern learning and feature transformation, and output layers for molecular phenotype prediction and disease association. This segmentation allows the system to achieve high productivity through automated processing while managing complexity through modular architecture where each layer performs a specific computational function.
Data Source
AI summary
The present disclosure provides methods and systems that can ascertain how genetic variants impact molecular phenotypes. Such methods and systems may use additional conservation information. In an aspect, the present disclosure provides a method for training a molecular phenotype neural network (MPNN), comprising: (a) providing a molecular phenotype neural network (MPNN) comprising one or more parameters; (b) providing a training data set comprising (i) a set of one or more inputs comprising biological sequences and (ii) for each input in the set of one or more inputs, a set of one or more molecular phenotypes corresponding to the input; (c) configuring the one or more parameters of the MPNN based on the training data set to minimize a total loss of the training data set, thereby training the MPNN; and (d) outputting the one or more parameters of the MPNN.